Re: ... unfinished business

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

jermainejackson

Rank: Treasurer [?]

Points: 267 [?]

Votes: 18 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: ... unfinished business

in response to

Re: ... unfinished business

Mazola

posted on Oct 31, 2018 08:29PM

The optimistic shareholder says "King Midas"

the mostly cynical, slightly hopeful, long time shareholder says two face from Batman - one side says Zenith transaction coming shortly, the other side says ha ha - one side says Large Pharma interest for the last ten years, the other side says show me any interest.

7 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply